Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Essential Hypertension

Interventions

DRUG

Placebo Single IV (Intravenous) Infusion

0.9% Sodium Chloride - 30 minute IV infusion

DRUG

Experimental: Single IV Infusion Vasomera (PB1046)

Trial Locations (1)

New Orleans Center for Clinical Research - Knoxville, Knoxville